At a glance
(thousands of €, if not stated otherwise) |
Year ended 31 December 2019 |
Year ended 31 December 2018 |
Year ended 31 December 2017 |
||||
---|---|---|---|---|---|---|---|
|
|||||||
INCOME STATEMENT |
|
|
|
||||
Revenues |
844,985 |
288,836 |
127,087 |
||||
Other income |
50,905 |
29,009 |
28,830 |
||||
R&D expenditure |
(427,320) |
(322,875) |
(218,502) |
||||
S, G&A expenses |
(98,278) |
(39,776) |
(27,218) |
||||
Operating expenses |
(525,597) |
(362,652) |
(245,720) |
||||
Operating profit/loss (-) |
370,292 |
(44,807) |
(89,802) |
||||
Net financial results |
(220,233) |
15,598 |
(25,705) |
||||
Taxes |
(214) |
(50) |
(198) |
||||
Net profit/loss (-) |
149,845 |
(29,259) |
(115,704) |
||||
|
|
|
|
||||
BALANCE SHEET |
|
|
|
||||
Cash and cash equivalents |
1,861,616 |
1,290,796 |
1,151,211 |
||||
Current financial investments |
3,919,216 |
– |
– |
||||
R&D incentives receivables |
115,356 |
84,646 |
75,783 |
||||
Assets (*) |
6,068,609 |
1,439,496 |
1,286,274 |
||||
Shareholders' equity (*) |
2,875,658 |
1,214,249 |
1,011,983 |
||||
Deferred income |
3,000,646 |
149,801 |
219,892 |
||||
Other liabilities (*) |
192,305 |
75,446 |
54,399 |
||||
|
|
|
|
||||
CASH FLOW |
|
|
|
||||
Operational cash flow/operational cash burn (-) (**) |
3,162,804 |
(158,384) |
(154,089) |
||||
Cash flow generated/used (-) in operating activities (*) |
3,208,617 |
(142,466) |
(147,030) |
||||
Cash flow used in investing activities |
(3,764,660) |
(15,914) |
(549) |
||||
Cash flow generated in financing activities (*) |
1,335,751 |
287,876 |
353,357 |
||||
Increase in cash and cash equivalents |
779,708 |
129,497 |
205,778 |
||||
Transfer to current financial investments |
(198,922) |
– |
– |
||||
Effect of currency exchange rate fluctuation on cash and cash equivalents |
(9,966) |
10,089 |
(27,808) |
||||
Cash and cash equivalents on 31 December |
1,861,616 |
1,290,796 |
1,151,211 |
||||
|
|
|
|
||||
Current financial investments on 31 December |
3,919,216 |
– |
– |
||||
Total current financial investments and cash and cash equivalents on 31 December |
5,780,832 |
1,290,796 |
1,151,211 |
||||
FINANCIAL RATIOS |
|
|
|
||||
Number of shares issued on 31 December |
64,666,802 |
54,465,421 |
50,936,778 |
||||
Basic income/loss (-) per share (in €) |
2.60 |
(0.56) |
(2.34) |
||||
Diluted income/loss (-) per share (in €) |
2.49 |
(0.56) |
(2.34) |
||||
Share price on 31 December (in €) |
186.50 |
80.56 |
78.98 |
||||
Total group employees on 31 December (number) |
1,003 |
725 |
600 |